Holen Sie sich die Stockscreener-App
9.31
1.92%
0.1751
Schlusskurs vom Vortag:
$9.1349
Offen:
$9.32
24-Stunden-Volumen:
3,566
Relative Volume:
0.64
Marktkapitalisierung:
$6.33B
Einnahmen:
$277.56M
Nettoeinkommen (Verlust:
$-13.33M
KGV:
-49.00
EPS:
-0.19
Netto-Cashflow:
$-6.54M
1W Leistung:
-7.18%
1M Leistung:
+15.08%
6M Leistung:
+13.81%
1J Leistung:
-2.51%
1-Tages-Spanne:
$8.6885
$9.32
1-Wochen-Bereich:
$8.6885
$9.9999
52-Wochen-Spanne:
$6.65
$11.07
Pharming Group N V Adr Stock (PHAR) Company Profile
Firmenname
Pharming Group N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PHAR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
9.31 | 685.98M | 277.56M | -13.33M | -6.54M | -0.19 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | Jefferies | Buy |
Pharming Group N V Adr Aktie (PHAR) Neueste Nachrichten
Pharming To Attend The H.C. Wainwright BioConnect Investor Conference 2023 - Barchart.com
SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock? - Nasdaq
META_TITLE_SECTORS - Yahoo Finance
Pharming Group to participate in March investor conference - GlobeNewswire Inc.
Pharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average – Time to Sell? - Defense World
Pharming Group N.V. (AMS:PHARM) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com India
H.C. Wainwright reiterates Buy on Pharming stock, pediatric trial shows safety and tolerability - Investing.com India
Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com India
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com
Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com
October 2024's Promising Penny Stocks to Watch - Yahoo Finance
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
RGC Stock Quote Price and Forecast - CNN
symbol__ Stock Quote Price and Forecast - CNN
Why Earnings Season Could Be Great for Pharming Group (PHAR) - Yahoo Finance
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Are Medical Stocks Lagging Lantheus (LNTH) This Year? - Nasdaq
Pharming Group (PHAR) - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Finanzdaten der Pharming Group N V Adr-Aktie (PHAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
7.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):